Also from this source

You just read:

Microbiotix Announces Exclusive Worldwide Licensing Agreement for HCV NS5B Non-Nucleoside Polymerase Inhibitors

News provided by

Microbiotix, Inc.

Jan 02, 2013, 03:00 EST